Aytu BioPharma Ownership | Who Owns Aytu BioPharma?


OverviewRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary


Aytu BioPharma is owned by 55.69% institutional investors, 7.58% insiders, and 36.74% retail investors. Nantahala capital management is the largest institutional shareholder, holding 17.72% of AYTU shares. Philotimo Focused Growth and Income is the top mutual fund, with 2.11% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAytu BioPharma55.69%7.58%36.74%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.67%11.42%44.91%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management1.09M17.72%$2.37M
Stonepine capital management812.68K13.25%$1.77M
Awm investment company619.87K10.10%$1.35M
Kanen wealth management573.36K9.35%$1.25M
Fny investment advisers35.92K0.59%$78.00K
Blackrock funding, inc. /de22.79K0.37%$49.69K
Hrt financial lp19.99K0.33%$43.00K
Acadian asset management10.24K0.17%$22.00K
Mai capital management3.58K0.06%$7.79K
Cibc private wealth group83.000.00%$181.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management812.68K1.74%$1.77M
Kanen wealth management573.36K0.48%$1.25M
Awm investment company619.87K0.15%$1.35M
Nantahala capital management1.09M0.09%$2.37M
Fny investment advisers35.92K0.03%$78.00K
Hrt financial lp19.99K0.00%$43.00K
Mai capital management3.58K0.00%$7.79K
Raymond james financial55.00-$120.00
Sjs investment consulting---
Vision financial markets2.00-$5.00

Top Buyers

HolderShares% AssetsChange
Awm investment company619.87K0.15%619.87K
Kanen wealth management573.36K0.48%573.36K
Stonepine capital management812.68K1.74%348.95K
Fny investment advisers35.92K0.03%35.92K
Hrt financial lp19.99K0.00%19.99K

Top Sellers

HolderShares% AssetsChange
Armistice capital---57.60K
Acadian asset management10.24K--4.38K
Jones financial companies lllp1.00--11.00
Sjs investment consulting---5.00
Cibc private wealth group83.00--

New Positions

HolderShares% AssetsChangeValue
Awm investment company619.87K0.15%619.87K$1.35M
Kanen wealth management573.36K0.48%573.36K$1.25M
Fny investment advisers35.92K0.03%35.92K$78.00K
Hrt financial lp19.99K0.00%19.99K$43.00K
Raymond james financial55.00-55.00$120.00

Sold Out

HolderChange
Sjs investment consulting-5.00
Armistice capital-57.60K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025307.14%3,416,18182.04%555.95%129.09%6200.00%
Mar 31, 202528-1,876,599-0.22%303.25%11-8.33%2-60.00%
Dec 31, 20242821.74%1,880,741-8.18%303.97%12140.00%5-28.57%
Sep 30, 202423-14.81%2,048,299-0.27%272.02%5-50.00%716.67%
Jun 30, 2024273.85%2,053,77514.39%373.52%10-16.67%620.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Philotimo Focused Growth and Income189.21K2.11%189.21K
Vanguard Institutional Extnd Mkt Idx Tr62.53K0.70%34.65K
Fidelity Extended Market Index31.99K0.36%-
Spartan Extended Market Index Pool E11.89K0.19%280.00
Spartan Extended Market Index Pool F12.20K0.14%-
Fidelity Series Total Market Index8.05K0.09%-
Northern Trust Extended Eq Market Idx6.31K0.07%-
NT Ext Equity Mkt Idx Fd - L6.31K0.07%-
Dimensional US Sustainability Core 1 ETF3.85K0.06%-
DFA US Targeted Value I3.66K0.06%-5.01K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Disbrow Jarrett Chief Business OfficerBuy$25.00K
Jun 09, 2025Disbrow Joshua R. Chief Executive OfficerBuy$100.00K
Jun 06, 2025Nantahala Capital Management, LLC-Buy$400.00
Feb 28, 2025Disbrow Joshua R. Chief Executive OfficerBuy$19.50K
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q11-
2024 Q4--
2024 Q3--
2024 Q2--

AYTU Ownership FAQ


Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 55.69%, followed by 7.58% insiders and 36.73% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.67%, which Aytu BioPharma exceeds.

Who owns the most shares of Aytu BioPharma?

Aytu BioPharma’s largest shareholders are Nantahala capital management (1.09M shares, 17.72%), Stonepine capital management (812.68K shares, 13.25%), and Awm investment company (619.87K shares, 10.10%). Together, they hold 41.07% of Aytu BioPharma’s total shares outstanding.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is Aytu BioPharma’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Aytu BioPharma’s biggest shareholder by percentage of total assets invested, with 1.74% of its assets in 812.68K Aytu BioPharma shares, valued at 1.77M$.

Who is the top mutual fund holder of Aytu BioPharma shares?

Philotimo Focused Growth and Income is the top mutual fund holder of Aytu BioPharma shares, with 2.11% of its total shares outstanding invested in 189.21K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools